Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020.
Lagi F, Piccica M, Graziani L, Vellere I, Botta A, Tilli M, Ottino L, Borchi B, Pozzi M, Bartalesi F, Mencarini J, Spinicci M, Zammarchi L, Pieralli F, Zagli G, Nozzoli C, Romagnoli S, Bartoloni A; COCORA working group; COCORA working group members not listed as individual author. Lagi F, et al. Among authors: graziani l. Euro Surveill. 2020 Apr;25(17):2000556. doi: 10.2807/1560-7917.ES.2020.25.17.2000556. Euro Surveill. 2020. PMID: 32372754 Free PMC article.
High-dose steroids for the treatment of severe COVID-19.
Piccica M, Lagi F, Trotta M, Spinicci M, Zammarchi L, Bartoloni A; COCORA Working Group. Piccica M, et al. Intern Emerg Med. 2021 Aug;16(5):1395-1399. doi: 10.1007/s11739-021-02707-x. Epub 2021 Apr 15. Intern Emerg Med. 2021. PMID: 33856664 Free PMC article. No abstract available.
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
Lagi F, Trevisan S, Piccica M, Graziani L, Basile G, Mencarini J, Borchi B, Menicacci L, Vaudo M, Scotti V, Fabbri A, Bandini G, Tozzetti C, Berni A, Aiezza N, Pestelli G, Turchi V, Pignone AM, Poggesi L, Nozzoli C, Morettini A, Rossolini GM, Bartoloni A. Lagi F, et al. Among authors: graziani l. Int J Infect Dis. 2021 Jul;108:231-236. doi: 10.1016/j.ijid.2021.04.065. Epub 2021 Apr 24. Int J Infect Dis. 2021. PMID: 33901656 Free PMC article.
Strongyloidiasis in the COVID era: a warning for an implementation of the screening protocol.
Vellere I, Graziani L, Tilli M, Mantella A, Campolmi I, Mencarini J, Borchi B, Spinicci M, Antonelli A, Rossolini GM, Bartoloni A, Zammarchi L. Vellere I, et al. Among authors: graziani l. Infection. 2021 Oct;49(5):1065-1067. doi: 10.1007/s15010-021-01621-w. Epub 2021 May 10. Infection. 2021. PMID: 33970429 Free PMC article. No abstract available.
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center.
Spinicci M, Vellere I, Graziani L, Tilli M, Borchi B, Mencarini J, Campolmi I, Gori L, Rasero L, Fattirolli F, Olivotto I, Lavorini F, Marchionni N, Zammarchi L, Bartoloni A; Careggi Post-acute COVID-19 Study Group. Spinicci M, et al. Among authors: graziani l. Open Forum Infect Dis. 2021 Feb 4;8(3):ofab049. doi: 10.1093/ofid/ofab049. eCollection 2021 Mar. Open Forum Infect Dis. 2021. PMID: 34109256 Free PMC article.
AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection.
Spinicci M, Mazzoni A, Borchi B, Graziani L, Mazzetti M, Bartalesi F, Botta A, Tilli M, Pieralli F, Coppi M, Giovacchini N, Colao MG, Saccardi R, Rossolini GM, Annunziato F, Bartoloni A. Spinicci M, et al. Among authors: graziani l. Eur J Immunol. 2022 Feb;52(2):352-355. doi: 10.1002/eji.202149574. Epub 2021 Dec 4. Eur J Immunol. 2022. PMID: 34822185 Free PMC article.
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications.
Spinicci M, Mazzoni A, Coppi M, Antonelli A, Salvati L, Maggi L, Basile G, Graziani L, Di Lauria N, Di Pilato V, Kiros ST, Beccastrini E, Saccardi R, Angileri M, Cecchi M, Cusi MG, Rossolini GM, Annunziato F, Bartoloni A, Parronchi P. Spinicci M, et al. Among authors: graziani l. J Clin Immunol. 2022 Oct;42(7):1371-1378. doi: 10.1007/s10875-022-01313-6. Epub 2022 Jul 2. J Clin Immunol. 2022. PMID: 35779200 Free PMC article.
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization.
Lamacchia G, Mazzoni A, Spinicci M, Vanni A, Salvati L, Peruzzi B, Bencini S, Capone M, Carnasciali A, Farahvachi P, Rocca A, Kiros ST, Graziani L, Zammarchi L, Mencarini J, Colao MG, Caporale R, Liotta F, Cosmi L, Rossolini GM, Bartoloni A, Maggi L, Annunziato F. Lamacchia G, et al. Among authors: graziani l. J Clin Immunol. 2022 Oct;42(7):1379-1391. doi: 10.1007/s10875-022-01325-2. Epub 2022 Jul 9. J Clin Immunol. 2022. PMID: 35809212 Free PMC article.
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes.
Spinicci M, Graziani L, Tilli M, Nkurunziza J, Vellere I, Borchi B, Mencarini J, Campolmi I, Gori L, Giovannoni L, Amato C, Livi L, Rasero L, Fattirolli F, Marcucci R, Giusti B, Olivotto I, Tomassetti S, Lavorini F, Maggi L, Annunziato F, Marchionni N, Zammarchi L, Bartoloni A. Spinicci M, et al. Among authors: graziani l. Viruses. 2022 Oct 27;14(11):2367. doi: 10.3390/v14112367. Viruses. 2022. PMID: 36366465 Free PMC article.
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19.
Graziani L, Gori L, Manciulli T, Basile G, Campolmi I, Borchi B, di Dio M, Mattei M, Ciurleo G, Ciliberti M, Malentacchi F, Coppi M, Morettini A, Parronchi P, Rossolini GM, Bartoloni A, Tomassetti S, Spinicci M. Graziani L, et al. J Antimicrob Chemother. 2023 Feb 1;78(2):555-558. doi: 10.1093/jac/dkac433. J Antimicrob Chemother. 2023. PMID: 36544352 Free PMC article. No abstract available.
130 results